Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 145Parkinson Disease 4, Autosomal Dominant Lewy Body 120Melanoma 84Squamous Cell Carcinoma of Head and Neck 56Neoplasms 44Breast Neoplasms 41Stomach Neoplasms 39Colorectal Neoplasms 38Triple Negative Breast Neoplasms 37Neoplasm Metastasis 36Carcinoma, Renal Cell 36Ovarian Neoplasms 30Lung Neoplasms 30Head and Neck Neoplasms 29Urinary Bladder Neoplasms 28Carcinoma, Transitional Cell 26Carcinoma, Hepatocellular 26Pancreatic Neoplasms 23Esophageal Neoplasms 20Endometrial Neoplasms 16Recurrence 15Prostatic Neoplasms 15Multiple Myeloma 15Fallopian Tube Neoplasms 15Carcinoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 13Small Cell Lung Carcinoma 12Lymphoma, Follicular 12Lymphoma, Non-Hodgkin 11

Interventions

Doxorubicin 6pazopanib 5Gemcitabine 4pembrolizumab 3Trabectedin 3Sorafenib 3Docetaxel 3Dacarbazine 3eribulin 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2Nivolumab 2Letrozole 2Ifosfamide 2Bevacizumab 2tremelimumab 1temsirolimus 1saracatinib 1sapanisertib 1rucaparib 1romidepsin 1olaratumab 1mocetinostat 1liposomal doxorubicin 1lenvatinib 1indolepropanol phosphate 1durvalumab 1cixutumumab 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Leiomyosarcoma × pembrolizumab × Clear all
NCT02406781 2025-12-10

PEMBROSARC

Institut Bergonié

Phase 2 Completed
129 enrolled 17 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Osteosarcoma

NCT03899805 2025-08-28

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

Dana-Farber Cancer Institute

Phase 2 Completed
57 enrolled 14 charts
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT04099277 2021-08-31

A Study of LY3435151 in Participants With Solid Tumors

Eli Lilly and Company

Phase 1 Terminated
2 enrolled 8 charts
BreastGastrointestinalGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡